193 related articles for article (PubMed ID: 31461854)
1.
Peng X; Zhang R; Wang C; Yu F; Yu M; Chen S; Fan Q; Xi Y; Duan G
Cells; 2019 Aug; 8(9):. PubMed ID: 31461854
[TBL] [Abstract][Full Text] [Related]
2. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
3. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, Immunity, and Vaccine Development for the Gastric Pathogen Helicobacter pylori.
Ikuse T; Blanchard TG; Czinn SJ
Curr Top Microbiol Immunol; 2019; 421():1-19. PubMed ID: 31123883
[TBL] [Abstract][Full Text] [Related]
6. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
[TBL] [Abstract][Full Text] [Related]
9. An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites.
Sun N; Zhang R; Duan G; Peng X; Wang C; Fan Q; Chen S; Xi Y
BMC Biotechnol; 2017 Mar; 17(1):25. PubMed ID: 28264682
[TBL] [Abstract][Full Text] [Related]
10. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
11. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
[TBL] [Abstract][Full Text] [Related]
12. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
Xie W; Zhao W; Zou Z; Kong L; Yang L
Helicobacter; 2021 Jun; 26(3):e12807. PubMed ID: 33847026
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, immunity, and vaccines for Helicobacter infection.
Permin H; Andersen LP
Helicobacter; 2005; 10 Suppl 1():21-5. PubMed ID: 16178967
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
[TBL] [Abstract][Full Text] [Related]
17. An intranasal influenza virus vector vaccine protects against
Nie L; Huang Y; Cheng Z; Luo H; Zhan Y; Dou K; Ma C; Yu C; Luo C; Liu Z; Liu S; Zhu Y
J Virol; 2024 Mar; 98(3):e0192323. PubMed ID: 38358289
[No Abstract] [Full Text] [Related]
18. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
DeLyria ES; Nedrud JG; Ernst PB; Alam MS; Redline RW; Ding H; Czinn SJ; Xu J; Blanchard TG
Helicobacter; 2011 Jun; 16(3):169-78. PubMed ID: 21585602
[TBL] [Abstract][Full Text] [Related]
20. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
Harbour SN; Mitchell HM; Sutton P
Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
